|
| US FDA marketing nod for AMAG Pharma's Feraheme to treat anaemia |
3 Jul 09, 06:48 |
|
| AMAG Pharmaceuticals, Inc. announced that the US Food and Drug Administration (FDA) has granted marketing approval for Feraheme (ferumoxytol) Injection for intravenous (IV) use as an iron replacement therapy for the treatment of iron deficiency anaemia in adult patients with chronic kidney disease. |
| more |
|
